Literature DB >> 23300155

Goal-directed therapy in osteoporosis.

Eugene McCloskey1, William D Leslie.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23300155     DOI： 10.1002/jbmr.1859

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN： 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  5 in total

Review 1.  Osteoporosis: Treat-to-Target.

Authors:  E Michael Lewiecki
Journal:  Curr Osteoporos Rep       Date:  2017-04       Impact factor: 5.096

2.  Fracture prediction from repeat BMD measurements in clinical practice.

Authors:  W D Leslie; S L Brennan-Olsen; S N Morin; L M Lix
Journal:  Osteoporos Int       Date:  2015-08-05       Impact factor: 4.507

3.  Goal-directed treatment of osteoporosis in Europe.

Authors:  J A Kanis; E McCloskey; J Branco; M-L Brandi; E Dennison; J-P Devogelaer; S Ferrari; J-M Kaufman; S Papapoulos; J-Y Reginster; R Rizzoli
Journal:  Osteoporos Int       Date:  2014-09-09       Impact factor: 4.507

4.  Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis.

Authors:  F Vescini; R Attanasio; A Balestrieri; F Bandeira; S Bonadonna; V Camozzi; S Cassibba; R Cesareo; I Chiodini; C Maria Francucci; L Gianotti; F Grimaldi; R Guglielmi; B Madeo; C Marcocci; A Palermo; A Scillitani; E Vignali; V Rochira; M Zini
Journal:  J Endocrinol Invest       Date:  2016-03-11       Impact factor: 4.256

5.  Relationship Between Bone Mineral Density T-Score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment.

Authors:  S Ferrari; C Libanati; Celia Jow Fang Lin; J P Brown; F Cosman; E Czerwiński; L H de Gregόrio; J Malouf-Sierra; J-Y Reginster; A Wang; R B Wagman; E M Lewiecki
Journal:  J Bone Miner Res       Date:  2019-05-29       Impact factor: 6.741
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.